Uppsala Monitoring Centre: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
Tags: mobile edit mobile web edit
 
Line 36: Line 36:
[[Category:Organizations based in Uppsala]]
[[Category:Organizations based in Uppsala]]
[[Category:Organizations established in 1978]]
[[Category:Organizations established in 1978]]
<gallery>
File:Uppsala_Monitoring_Centre_facade_logo.jpg|Facade logo of Uppsala Monitoring Centre
</gallery>

Latest revision as of 22:01, 16 February 2025

Uppsala Monitoring Centre[edit]

Logo of the Uppsala Monitoring Centre

The Uppsala Monitoring Centre (UMC) is an independent, non-profit foundation and a centre for international service and scientific research in the field of pharmacovigilance. It is located in Uppsala, Sweden. UMC was established in 1978 to support the World Health Organization's (WHO) Programme for International Drug Monitoring.

History[edit]

The Uppsala Monitoring Centre was founded in 1978 as a result of a WHO initiative to create a global system for monitoring the safety of medicines. The centre was established in Uppsala, Sweden, due to the country's strong tradition in pharmaceutical research and development. Since its inception, UMC has played a crucial role in collecting and analyzing data on adverse drug reactions (ADRs) from around the world.

Functions[edit]

UMC's primary function is to manage the WHO Programme for International Drug Monitoring, which involves collecting and analyzing reports of adverse drug reactions from member countries. The centre maintains the VigiBase, the largest global database of ADRs, which is used to identify potential safety issues with medicines. UMC also develops tools and methodologies for signal detection and risk assessment in pharmacovigilance.

Research and Development[edit]

UMC is involved in various research projects aimed at improving the safety of medicines. The centre collaborates with academic institutions, regulatory authorities, and the pharmaceutical industry to advance the science of pharmacovigilance. UMC also provides training and education to healthcare professionals and regulatory staff worldwide.

Global Impact[edit]

The work of UMC has had a significant impact on global public health by improving the safety of medicines. The centre's efforts have led to the identification of numerous safety signals, resulting in changes to drug labels, withdrawal of unsafe medicines, and the development of safer therapeutic alternatives.

Related Pages[edit]

References[edit]

<references group="" responsive="1"></references>